Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hemangiosarcoma × Disulfides × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 18 Ovarian Neoplasms 13 Carcinoma, Non-Small-Cell Lung 13 Fallopian Tube Neoplasms 11 Colorectal Neoplasms 10 Pancreatic Neoplasms 8 Carcinoma, Hepatocellular 6 Urinary Bladder Neoplasms 5 Mycosis Fungoides 5 Melanoma 5 Lymphoma, T-Cell, Cutaneous 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Squamous Cell Carcinoma of Head and Neck 4 Prostatic Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Sezary Syndrome 3 Sarcoma 3 Neoplasms 3 Neoplasm Metastasis 3 Myelodysplastic Syndromes 3 Multiple Myeloma 3 Lymphoma, T-Cell 3 Leukemia, Myeloid, Acute 3 Carcinoma, Renal Cell 3 Urogenital Neoplasms 2 Urethral Neoplasms 2 Ureteral Neoplasms 2 Thyroid Neoplasms 2

Interventions

Paclitaxel 6 Doxorubicin 5 pembrolizumab 4 pazopanib 4 Gemcitabine 4 durvalumab 3 Radiotherapy 3 Propranolol 3 Docetaxel 3 Surveys and Questionnaires 2 Sunitinib 2 Standard of Care 2 Nivolumab 2 Ifosfamide 2 Bevacizumab 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 tremelimumab 1 trebananib 1 trastuzumab duocarmazine 1 talazoparib 1 spartalizumab 1 sintilimab 1 selinexor 1 sarilumab 1 ribociclib 1 regorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04668300 2025-10-09

DOSa

M.D. Anderson Cancer Center

Phase 2 Active not recruiting

Hemangiosarcoma, Liposarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡